Quantcast

Latest Targeted therapy Stories

2015-03-12 08:32:23

TAMPA, Fla., March 12, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.

2015-03-03 04:22:25

Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan LONDON, March 3, 2015 /PRNewswire/ -- Although lung

2015-02-26 08:32:18

Epic's circulating tumor cell analysis provides comprehensive, real-time information from a liquid biopsy that could help guide cancer treatments SAN DIEGO, Feb.

2015-02-26 08:31:04

Research Presented at 2015 Genitourinary Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Identifying Potential Treatment Strategies for Challenging Genitourinary Cancers

2015-02-23 16:31:35

Circulating tumor cell analysis provides comprehensive information from a real-time liquid biopsy that could help guide treatments for metastatic prostate cancers and bladder cancers SAN

2015-01-26 00:20:40

Novel Diagnostic Helping Answer U.S. President's Call for Action on Precision Medicine Initiative JERUSALEM, Jan.

2015-01-21 12:24:09

Second Orphan Designation for OncoSynergy's Novel Multi-Indication Platform Drug SAN FRANCISCO, Jan.

2015-01-21 04:21:02

Prospective clinical studies to evaluate Trovagene's Precision Cancer Monitoring platform to determine the emergence of resistance mutations using circulating tumor DNA SAN DIEGO,


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related